<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" > <channel> <title>Amide Technologies Archives - Slice of Healthcare</title> <atom:link href="https://sliceofhealthcare.com/tag/amide-technologies/feed/" rel="self" type="application/rss+xml" /> <link>https://sliceofhealthcare.com/tag/amide-technologies/</link> <description>Redefining Healthcare Media.</description> <lastBuildDate>Fri, 15 Dec 2023 08:08:18 +0000</lastBuildDate> <language>en-US</language> <sy:updatePeriod> hourly </sy:updatePeriod> <sy:updateFrequency> 1 </sy:updateFrequency> <generator>https://wordpress.org/?v=6.7.2</generator> <image> <url>https://i0.wp.com/sliceofhealthcare.com/wp-content/uploads/2023/05/cropped-Site-icon-slice-of-healthcare-2.png?fit=32%2C32&ssl=1</url> <title>Amide Technologies Archives - Slice of Healthcare</title> <link>https://sliceofhealthcare.com/tag/amide-technologies/</link> <width>32</width> <height>32</height> </image> <site xmlns="com-wordpress:feed-additions:1">190433015</site> <item> <title>Amide Technologies Revolutionizes Peptide Synthesis with Novel Manufacturing Platform and Secures $16.5M in Funding</title> <link>https://sliceofhealthcare.com/amide-technologies-revolutionizes-peptide-synthesis-with-novel-manufacturing-platform-and-secures-16-5m-in-funding/</link> <dc:creator><![CDATA[Chris-Anne Roque]]></dc:creator> <pubDate>Fri, 15 Dec 2023 08:07:07 +0000</pubDate> <category><![CDATA[Funding News]]></category> <category><![CDATA[News]]></category> <category><![CDATA[Amide Technologies]]></category> <category><![CDATA[Brad Pentelute]]></category> <category><![CDATA[Engine Ventures]]></category> <category><![CDATA[Forcefield Venture Fund]]></category> <category><![CDATA[Jeremy Wertheimer]]></category> <category><![CDATA[Mack Flinspach]]></category> <category><![CDATA[Mark Simon]]></category> <category><![CDATA[MIT Department of Chemistry]]></category> <category><![CDATA[Philip Dixon]]></category> <category><![CDATA[Reed Sturtevant]]></category> <category><![CDATA[The Salk Institute]]></category> <category><![CDATA[Velia Therapeutics]]></category> <guid isPermaLink="false">https://sliceofhealthcare.com/?p=13793</guid> <description><![CDATA[<p>Key Highlights Amide Technologies announces commercialization of a novel peptide manufacturing platform, significantly advancing the synthesis of long…</p> <p>The post <a href="https://sliceofhealthcare.com/amide-technologies-revolutionizes-peptide-synthesis-with-novel-manufacturing-platform-and-secures-16-5m-in-funding/">Amide Technologies Revolutionizes Peptide Synthesis with Novel Manufacturing Platform and Secures $16.5M in Funding</a> appeared first on <a href="https://sliceofhealthcare.com">Slice of Healthcare</a>.</p> ]]></description> <content:encoded><![CDATA[ <div data-elementor-type="wp-post" data-elementor-id="13793" class="elementor elementor-13793" data-elementor-post-type="post"> <section class="elementor-section elementor-top-section elementor-element elementor-element-53265ad elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="53265ad" data-element_type="section"> <div class="elementor-container elementor-column-gap-default"> <div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b1fd0d8" data-id="b1fd0d8" data-element_type="column"> <div class="elementor-widget-wrap elementor-element-populated"> <div class="elementor-element elementor-element-219a45b elementor-widget elementor-widget-heading" data-id="219a45b" data-element_type="widget" data-widget_type="heading.default"> <div class="elementor-widget-container"> <h2 id="key-highlights" class="elementor-heading-title elementor-size-default">Key Highlights</h2> </div> </div> </div> </div> </div> </section> <section class="elementor-section elementor-top-section elementor-element elementor-element-ea205cb elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="ea205cb" data-element_type="section"> <div class="elementor-container elementor-column-gap-default"> <div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-37761df" data-id="37761df" data-element_type="column"> <div class="elementor-widget-wrap elementor-element-populated"> <div class="elementor-element elementor-element-6d09b4b elementor-widget elementor-widget-text-editor" data-id="6d09b4b" data-element_type="widget" data-widget_type="text-editor.default"> <div class="elementor-widget-container"> <ul><li><strong>Amide Technologies announces commercialization of a novel peptide manufacturing platform</strong>, significantly advancing the synthesis of long peptides.</li><li><strong>The company raised a total of $16.5 million in funding</strong>, including a $7.5 million Series A Extension led by Engine Ventures and Forcefield Venture Fund.</li><li><strong>Developed at MIT, Amide’s platform can synthesize peptides up to 120 amino acids long</strong>, surpassing traditional Solid Phase Peptide Synthesis limits.</li><li><strong>Amide is partnering with The Salk Institute and Velia Therapeutics</strong> to manufacture complex peptides for groundbreaking therapeutic applications.</li><li><strong>The new funding will be used to scale operations, build additional instrumentation, and launch pilot programs</strong> with pharmaceutical partners.</li></ul><p><b>Source: </b><a href="https://www.businesswire.com/news/home/20231214964881/en/Amide-Technologies-Announces-Complex-Peptide-Manufacturing-Platform-Raises-16.5M-to-Expedite-Frontier-Drug-Discovery">Business Wire</a></p> </div> </div> </div> </div> </div> </section> <section class="elementor-section elementor-top-section elementor-element elementor-element-e90ba87 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="e90ba87" data-element_type="section"> <div class="elementor-container elementor-column-gap-default"> <div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0c976b7" data-id="0c976b7" data-element_type="column"> <div class="elementor-widget-wrap elementor-element-populated"> <div class="elementor-element elementor-element-5516a40 elementor-widget elementor-widget-heading" data-id="5516a40" data-element_type="widget" data-widget_type="heading.default"> <div class="elementor-widget-container"> <h2 id="notable-quotes" class="elementor-heading-title elementor-size-default">Notable Quotes</h2> </div> </div> </div> </div> </div> </section> <section class="elementor-section elementor-top-section elementor-element elementor-element-d697cb9 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="d697cb9" data-element_type="section"> <div class="elementor-container elementor-column-gap-default"> <div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0a4aada" data-id="0a4aada" data-element_type="column"> <div class="elementor-widget-wrap elementor-element-populated"> <div class="elementor-element elementor-element-91b3c7e elementor-widget elementor-widget-text-editor" data-id="91b3c7e" data-element_type="widget" data-widget_type="text-editor.default"> <div class="elementor-widget-container"> <ul><li>“Amide delivers on complex peptide orders that other vendors refuse because peptide sourcing shouldn’t stand in the way of discovery,” – <strong>Mark Simon, PhD, CEO at Amide Technologies</strong></li><li>“Amide is well-positioned to turbocharge today’s most exciting pharmaceutical frontiers,” – <strong>Reed Sturtevant, General Partner at Engine Ventures and Amide Board Member</strong></li><li>“Amide’s significant advances in peptide synthesis has allowed us to obtain synthetic versions of very long peptides which historically would have been intractable,” – <strong>Mack Flinspach, Executive Director, Protein Chemistry and Structural Biology at Velia, Inc</strong></li></ul> </div> </div> </div> </div> </div> </section> <section class="elementor-section elementor-top-section elementor-element elementor-element-de5db98 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="de5db98" data-element_type="section"> <div class="elementor-container elementor-column-gap-default"> <div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-49139f5" data-id="49139f5" data-element_type="column"> <div class="elementor-widget-wrap elementor-element-populated"> <div class="elementor-element elementor-element-416ad5a elementor-widget elementor-widget-heading" data-id="416ad5a" data-element_type="widget" data-widget_type="heading.default"> <div class="elementor-widget-container"> <h2 id="sohs-take" class="elementor-heading-title elementor-size-default">SoH's Take</h2> </div> </div> </div> </div> </div> </section> <section class="elementor-section elementor-top-section elementor-element elementor-element-815da73 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no" data-id="815da73" data-element_type="section"> <div class="elementor-container elementor-column-gap-default"> <div class="elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-123f65b" data-id="123f65b" data-element_type="column"> <div class="elementor-widget-wrap elementor-element-populated"> <div class="elementor-element elementor-element-e1455ae elementor-widget elementor-widget-text-editor" data-id="e1455ae" data-element_type="widget" data-widget_type="text-editor.default"> <div class="elementor-widget-container"> <p>Amide Technologies’ breakthrough in peptide synthesis marks a significant milestone in the biotech industry, addressing a long-standing challenge in peptide manufacturing. By extending the synthesis capability to peptides up to 120 amino acids, Amide not only surpasses the traditional limitations of Solid Phase Peptide Synthesis but also opens new avenues for therapeutic research and drug development. This innovation, coupled with substantial funding, positions Amide Technologies as a key player in accelerating pharmaceutical advancements. The collaboration with esteemed institutions and hiring of industry veterans further underscore the company’s commitment to leading the charge in peptide-based therapeutic solutions. The biotech sector should closely monitor Amide’s pioneering work, as it promises to bring forth novel therapeutic modalities and significantly reduce the time from drug conception to testing, a crucial factor in the fast-paced world of medical research and development.</p> </div> </div> </div> </div> </div> </section> </div> <p><a class="a2a_button_linkedin" href="https://www.addtoany.com/add_to/linkedin?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Famide-technologies-revolutionizes-peptide-synthesis-with-novel-manufacturing-platform-and-secures-16-5m-in-funding%2F&linkname=Amide%20Technologies%20Revolutionizes%20Peptide%20Synthesis%20with%20Novel%20Manufacturing%20Platform%20and%20Secures%20%2416.5M%20in%20Funding" title="LinkedIn" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Famide-technologies-revolutionizes-peptide-synthesis-with-novel-manufacturing-platform-and-secures-16-5m-in-funding%2F&linkname=Amide%20Technologies%20Revolutionizes%20Peptide%20Synthesis%20with%20Novel%20Manufacturing%20Platform%20and%20Secures%20%2416.5M%20in%20Funding" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Famide-technologies-revolutionizes-peptide-synthesis-with-novel-manufacturing-platform-and-secures-16-5m-in-funding%2F&linkname=Amide%20Technologies%20Revolutionizes%20Peptide%20Synthesis%20with%20Novel%20Manufacturing%20Platform%20and%20Secures%20%2416.5M%20in%20Funding" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_email" href="https://www.addtoany.com/add_to/email?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Famide-technologies-revolutionizes-peptide-synthesis-with-novel-manufacturing-platform-and-secures-16-5m-in-funding%2F&linkname=Amide%20Technologies%20Revolutionizes%20Peptide%20Synthesis%20with%20Novel%20Manufacturing%20Platform%20and%20Secures%20%2416.5M%20in%20Funding" title="Email" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_copy_link" href="https://www.addtoany.com/add_to/copy_link?linkurl=https%3A%2F%2Fsliceofhealthcare.com%2Famide-technologies-revolutionizes-peptide-synthesis-with-novel-manufacturing-platform-and-secures-16-5m-in-funding%2F&linkname=Amide%20Technologies%20Revolutionizes%20Peptide%20Synthesis%20with%20Novel%20Manufacturing%20Platform%20and%20Secures%20%2416.5M%20in%20Funding" title="Copy Link" rel="nofollow noopener" target="_blank"></a><a class="a2a_dd addtoany_share_save addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fsliceofhealthcare.com%2Famide-technologies-revolutionizes-peptide-synthesis-with-novel-manufacturing-platform-and-secures-16-5m-in-funding%2F&title=Amide%20Technologies%20Revolutionizes%20Peptide%20Synthesis%20with%20Novel%20Manufacturing%20Platform%20and%20Secures%20%2416.5M%20in%20Funding" data-a2a-url="https://sliceofhealthcare.com/amide-technologies-revolutionizes-peptide-synthesis-with-novel-manufacturing-platform-and-secures-16-5m-in-funding/" data-a2a-title="Amide Technologies Revolutionizes Peptide Synthesis with Novel Manufacturing Platform and Secures $16.5M in Funding"></a></p><p>The post <a href="https://sliceofhealthcare.com/amide-technologies-revolutionizes-peptide-synthesis-with-novel-manufacturing-platform-and-secures-16-5m-in-funding/">Amide Technologies Revolutionizes Peptide Synthesis with Novel Manufacturing Platform and Secures $16.5M in Funding</a> appeared first on <a href="https://sliceofhealthcare.com">Slice of Healthcare</a>.</p> ]]></content:encoded> <post-id xmlns="com-wordpress:feed-additions:1">13793</post-id> </item> </channel> </rss>